PharmaResearch Statistics

Total Valuation

PharmaResearch has a market cap or net worth of KRW 1.91 trillion. The enterprise value is 1.77 trillion.

Market Cap	1.91T
Enterprise Value	1.77T

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

PharmaResearch has 10.34 million shares outstanding. The number of shares has increased by 11.98% in one year.

Shares Outstanding	10.34M
Shares Change (YoY)	+11.98%
Shares Change (QoQ)	+17.05%
Owned by Insiders (%)	38.89%
Owned by Institutions (%)	22.21%
Float	6.32M

Valuation Ratios

The trailing PE ratio is 22.30 and the forward PE ratio is 16.76. PharmaResearch's PEG ratio is 0.71.

PE Ratio	22.30
Forward PE	16.76
PS Ratio	6.36
PB Ratio	3.95
P/FCF Ratio	24.11
PEG Ratio	0.71

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.20, with an EV/FCF ratio of 22.31.

EV / Earnings	19.47
EV / Sales	5.96
EV / EBITDA	14.20
EV / EBIT	15.79
EV / FCF	22.31

Financial Position

The company has a current ratio of 3.68, with a Debt / Equity ratio of 6.88.

Current Ratio	3.68
Quick Ratio	2.85
Debt / Equity	6.88
Debt / EBITDA	0.30
Debt / FCF	0.44
Interest Coverage	78.52

Financial Efficiency

Return on equity (ROE) is 19.64% and return on invested capital (ROIC) is 13.02%.

Return on Equity (ROE)	19.64%
Return on Assets (ROA)	11.91%
Return on Capital (ROIC)	13.02%
Revenue Per Employee	735.96M
Profits Per Employee	225.17M
Employee Count	403
Asset Turnover	0.54
Inventory Turnover	1.81

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.99% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+42.99%
50-Day Moving Average	159,964.00
200-Day Moving Average	126,557.50
Relative Strength Index (RSI)	59.19
Average Volume (20 Days)	312,708

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaResearch had revenue of KRW 296.59 billion and earned 90.74 billion in profits. Earnings per share was 8,276.27.

Revenue	296.59B
Gross Profit	211.00B
Operating Income	105.30B
Pretax Income	115.82B
Net Income	90.74B
EBITDA	117.81B
EBIT	105.30B
Earnings Per Share (EPS)	8,276.27

Full Income Statement

Balance Sheet

The company has 206.07 billion in cash and 35.05 billion in debt, giving a net cash position of 171.02 billion or 16,533.11 per share.

Cash & Cash Equivalents	206.07B
Total Debt	35.05B
Net Cash	171.02B
Net Cash Per Share	16,533.11
Equity (Book Value)	509.11B
Book Value Per Share	46,706.30
Working Capital	227.30B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 104.28 billion and capital expenditures -25.08 billion, giving a free cash flow of 79.20 billion.

Operating Cash Flow	104.28B
Capital Expenditures	-25.08B
Free Cash Flow	79.20B
FCF Per Share	7,656.15

Full Cash Flow Statement

Margins

Gross margin is 71.14%, with operating and profit margins of 35.50% and 30.60%.

Gross Margin	71.14%
Operating Margin	35.50%
Pretax Margin	39.05%
Profit Margin	30.60%
EBITDA Margin	39.72%
EBIT Margin	35.50%
FCF Margin	26.70%

Dividends & Yields

This stock pays an annual dividend of 950.00, which amounts to a dividend yield of 0.50%.

Dividend Per Share	950.00
Dividend Yield	0.50%
Dividend Growth (YoY)	43.94%
Years of Dividend Growth	4
Payout Ratio	11.54%
Buyback Yield	-11.98%
Shareholder Yield	-11.48%
Earnings Yield	4.48%
FCF Yield	4.15%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a